Trial Profile
Phase II study of weekly fractionated hepatic arterial infusion of Sorafenib and Cisplatin for advanced hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Feb 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Aug 2012 New trial record